Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

30 May 19
Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplace Conference, Jefferies 2019 Healthcare Conference and Stifel 2019 Cross Sector Insight Conference
TORONTO , May 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“ Cronos Group” or the “Company”) (TSX: CRON) (Nasdaq: CRON), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at three industry conferences in
29 May 19
Cronos Group Inc. Sets Date for 2019 Annual Meeting of Shareholders
TORONTO , May 29, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m.
14 May 19
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement  TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with

SEC Filings

Filing date Description

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

14 August 2018 at 8:00 AM EDT
Second Quarter 2018 Earnings Conference Call
04 March 2018 at 8:30 AM EST
Landmark Partnership with Ginkgo Bioworks Conference Call